デフォルト表紙
市場調査レポート
商品コード
1098624

rHuアルブミンの市場規模・シェア・展望・機会 (2022年~2030年):原料・用途 (細胞培養培地・幹細胞治療・製剤・凍結保存・その他)・エンドユーザー・地域別

rHu Albumin Market, by Source, by Application (Cell Culture Media, Stem Cell Therapy, Drug Formulations, Cryopreservation, and Others), by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 160 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
rHuアルブミンの市場規模・シェア・展望・機会 (2022年~2030年):原料・用途 (細胞培養培地・幹細胞治療・製剤・凍結保存・その他)・エンドユーザー・地域別
出版日: 2022年06月16日
発行: Coherent Market Insights
ページ情報: 英文 160 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

参入事業者による販売契約などのさまざま戦略への注力や、研究機関や学術機関によるR&D活動への注力が予測期間にわたって世界のrHuアルブミン市場の成長を促進すると予想されています。

当レポートでは、世界のrHuアルブミンの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制・償還環境、パイプラインの分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • ポーターの分析
  • 産業動向
  • 主なハイライト
  • 疫学
  • 償還シナリオ
  • 規制シナリオ
  • 製品の発売・承認
  • 買収・提携シナリオ

第4章 世界のrHuアルブミン市場:COVID-19の影響

  • COVID-19:疫学
  • rHuアルブミンの需要と供給に対する影響
  • ヘルスケア部門全体に対する影響

第5章 世界のrHuアルブミン市場:原料別

  • オリザサティバ
  • ピキアパストリス
  • その他

第6章 世界のrHuアルブミン市場:用途別

  • 細胞培養培地
  • 栄養素・安定剤
  • 培地サプリメント
  • 幹細胞治療
  • 製剤
  • 凍結保存
  • その他

第7章 世界のrHuアルブミン市場:エンドユーザー別

  • 製薬・バイオテクノロジー産業
  • 研究機関

第8章 世界のrHuアルブミン市場:地域別

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第9章 競合情勢

  • 企業プロファイル
    • Merck KGaA
    • HiMedia Laboratories Pvt. Ltd.
    • Albumin Bioscience
    • Albumedix
    • ScienCell Research Laboratories, Inc.
    • InVitria
    • Lazuline Biotech Private Limited
    • Lee Biosolutions, Inc.
    • Abcam Plc
    • Shandong Kingtone Biotechnology Co.,Ltd.

第10章 セクション

目次
Product Code: CMI5040

A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. They are manufactured using stem cells, mammalian cells, etc., through tissue culture methods.

Tissue culture methods rely on cell culture medium, which contains a number of essential components such as carbohydrates, amino acids, vitamins, minerals, and a pH buffer system that keep the cell culture healthy and supply nutrition for the production of therapeutic recombinant molecules or biopharmaceuticals.

One such component of cell culture is recombinant human albumin. Recombinant human albumin (rHu) has applications in cell culture media and stem cell therapy. It is particularly a nutrient supplement and stabilizer in the cell culture medium. Moreover, it plays a role in cryopreservation for stem cell therapies.

Market Dynamics

Market players are focusing on various strategies such as distribution agreements which is expected to drive market growth over the forecast period. In April 2021, Albumedix, a science-driven, biotechnology Company, announced that they had entered into a distribution agreement with established and well recognized reagent supplier Fujifilm Wako Pure Chemical Corporation in Japan and China including Hong Kong.

Research and/or academic institutes are focused on research and development activities related to rHu albumin, which is expected to drive growth of the global rHu albumin market over the forecast period. For instance, in June 2019, The First Hospital of Jilin University, a leading national research university located in Changchun, China, initiated a phase I, single-center, randomized, double-blind, placebo-controlled single dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of recombinant human albumin injection in healthy volunteers for treatment of ascites.

Increasing research and development activities of rHu albumin in the region is expected to drive growth of the global rHu albumin market. For instance, according to a study published in clinicaltrials.gov, a trial, which started on April 8, 2021, is being conducted by Protgen Ltd, a research and development-oriented high-tech enterprise, based in Beijing, China. The trial is aimed at adopting a single-center, randomized, double-blind, dose-escalation, placebo-controlled design to evaluate the safety, tolerability, pharmacokinetics, and efficacy of a single administration of recombinant human serum albumin in healthy subjects. The study is estimated to be completed by December 31, 2022.

Key features of the study:

  • This report provides an in-depth analysis of the global rHu albumin market , provides market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global rHu albumin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Merck KGaA, HiMedia Laboratories Pvt. Ltd., Albumin Bioscience, Albumedix, ScienCell Research Laboratories, Inc., InVitria, Lazuline Biotech Private Limited, Lee Biosolutions, Inc., Abcam Plc, and Shandong Kingtone Biotechnology Co.,Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The Global rHu Albumin Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global rHu albumin market

Detailed Segmentation:

  • Global rHu Albumin Market , By Source:
    • Oryza sativa
    • Pichia pastoris
    • Others (Saccharomyces cerevisiae, etc.)
  • Global rHu Albumin Market , By Application:
    • Cell Culture Media
      • Nutrient and stabilizer
      • Medium Supplement
    • Stem Cell Therapy
    • Drug Formulations
    • Cryopreservation
    • Others
  • Global rHu Albumin Market , By End User:
    • Pharmaceutical & Biotechnological Industry
    • Research Institutes
  • Global rHu Albumin Market , By Region:
    • North America
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Merck KGaA *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • HiMedia Laboratories Pvt. Ltd.
    • Albumin Bioscience
    • Albumedix
    • ScienCell Research Laboratories, Inc.
    • InVitria
    • Lazuline Biotech Private Limited
    • Lee Biosolutions, Inc.
    • Abcam Plc
    • Shandong Kingtone Biotechnology Co.,Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. Global rHu Albumin Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of rHu Albumin
  • Impact of COVID-19 on the overall Healthcare Sector

5. Global rHu Albumin Market , By Source, 2017-2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oryza Sativa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Pichia pastoris
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global rHu Albumin Market , By Application, 2017-2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cell Culture Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Nutrient and stabilizer
  • Medium Supplement
  • Stem Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Drug Formulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cryopreservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global rHu Albumin Market , By End User, 2017-2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Pharmaceutical & Biotechnology Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global rHu Albumin Market , By Region, 2017-2030 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Market Size and Forecast, By Source, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2030 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Source, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Source, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Source, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Source, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Source, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Merck KGaA *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • HiMedia Laboratories Pvt. Ltd.
    • Albumin Bioscience
    • Albumedix
    • ScienCell Research Laboratories, Inc.
    • InVitria
    • Lazuline Biotech Private Limited
    • Lee Biosolutions, Inc.
    • Abcam Plc
    • Shandong Kingtone Biotechnology Co.,Ltd.

Key pointers provided are also applicable to other companies covered in the scope of the report.

10. Section

  • Research Methodology
  • About us
  • Contact